EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Competitive ELISA for the identification of 35–55 myelin oligodendrocyte glycoprotein immunodominant epitope conjugated with mannan

Areti Gkika, Maria-Eleni Androutsou, Alexios J Aletras, Theodore Tselios iD

Journal of Peptide Science · 2023

DOI: 10.1002/psc.3493 ↗

At a glance

Journal article in Journal of Peptide Science, 2023. Written by Areti Gkika and 3 co-authors. Institution: Department of Chemistry, University of Patras, Rion Patras, Greece. Major MEDLINE topics: Immunodominant Epitopes, Myelin-Oligodendrocyte Glycoprotein, Peptide Fragments, Multiple Sclerosis. Cited 2 times so far (Crossref); 31 references. The full text is freely available (open access, CC BY 4.0). Funded by: Operational Program Competitiveness, Entrepreneurship and Innovation.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Analogs of immunodominant myelin peptides involved in multiple sclerosis (MS: the most common autoimmune disease) have been extensively used to modify the immune response over the progression of the disease. The immunodominant 35–55 epitope of myelin oligodendrocyte glycoprotein (MOG 35–55 ) is an autoantigen appearing in MS and stimulates the encephalitogenic T cells, whereas mannan polysaccharide ( Saccharomyces cerevisiae ) is a carrier toward the mannose receptor of dendritic cells and macrophages. The conjugate of mannan‐MOG 35–55 has been extensively studied for the inhibition of chronic experimental autoimmune encephalomyelitis (EAE: an animal model of MS) by inducing antigen‐specific immune tolerance against the clinical symptoms of EAE in mice. Moreover, it presents a promising approach for the immunotherapy of MS under clinical investigation. In this study, a competitive enzyme‐linked immunosorbent assay (ELISA) was developed to detect the MOG 35–55 peptide that is conjugated to mannan. Intra‐ and inter ‐day assay experiments proved that the proposed ELISA methodology is accurate and reliable and could be used in the following applications: (i) to identify the peptide (antigen) while it is conjugated to mannan and (ii) to adequately address the alterations that the MOG 35–55 peptide may undergo when it is bound to mannan during production and stability studies.

Subjects

MeSH terms (MEDLINE)

Immunodominant EpitopesMyelin-Oligodendrocyte GlycoproteinPeptide FragmentsMultiple SclerosisAnimalsMiceEncephalomyelitis, Autoimmune, ExperimentalEnzyme-Linked Immunosorbent AssayMannansMice, Inbred C57BL

Author keywords

competitive ELISAmannanmultiple sclerosismyelin oligodendrocyte glycoprotein

Substances

Immunodominant EpitopesMannansMyelin-Oligodendrocyte GlycoproteinPeptide Fragmentsmyelin oligodendrocyte glycoprotein (35-55)

Authors and institutions

  • Department of Chemistry, University of Patras, Rion Patras, Greece.
  • Vianex S.A., Nea Erythrea, Greece.

ORCID profiles: Theodore Tselios

Funding

  • Operational Program Competitiveness, Entrepreneurship and Innovation

Cite

APA

Gkika, A., Androutsou, M. E., Aletras, A. J., & Tselios, T. (2023). Competitive ELISA for the identification of 35–55 myelin oligodendrocyte glycoprotein immunodominant epitope conjugated with mannan. Journal of Peptide Science. https://doi.org/10.1002/psc.3493

Vancouver

Gkika A, Androutsou ME, Aletras AJ, Tselios T. Competitive ELISA for the identification of 35–55 myelin oligodendrocyte glycoprotein immunodominant epitope conjugated with mannan. Journal of Peptide Science. 2023. doi:10.1002/psc.3493

BibTeX
@article{Gkika2023,
  author = {Gkika, Areti and Androutsou, Maria-Eleni and Aletras, Alexios J and Tselios, Theodore},
  title = {Competitive ELISA for the identification of 35–55 myelin oligodendrocyte glycoprotein immunodominant epitope conjugated with mannan},
  journal = {Journal of Peptide Science},
  year = {2023},
  doi = {10.1002/psc.3493}
}
Start for free →